In order to find a cost-effective prognostic biomarker for cancer patients, biochemical markers of inflammation (leucocytes and their subtypes, levels of some cytokines, CRP, albumin) have been incorporated in prognostic factors for numerous types of cancer [56]. This evidence concerns the gene CRP and cancer.